Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus

Cited by (1,000)

Items 701–800 of 1,000

1. Interaction between Alzheimer's disease βA4 precursor protein (APP) and the extracellular matrix: Evidence for the participation of heparan sulfate proteoglycans
   Jorge Cáceres, Enrique Brandan · 1997 · Journal of Cellular Biochemistry
2. Present state and future development of the therapy of Alzheimer disease
   Massimo F L Pomponi, E. Giacobini, Martina Brufani · 1990 · Aging Clinical and Experimental Research
3. Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration.
   Kerstin Iverfeldt, Sven Ivar Walaas, Paul Greengard · 1993 · Proceedings of the National Academy of Sciences
4. Alzheimer’s Disease and the Blood–Brain Barrier: Past, Present and Future
   Gene L. Bowman, Joseph F. Quinn · 2008 · Aging Health
5. Tangle-associated neuritic clusters. A new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with beta/A4.
   David G. Muñoz, D Wang · 1992 · PubMed Central
6. Expression of active secreted forms of human amyloid beta-protein precursor by recombinant baculovirus-infected insect cells.
   Ramaninder Bhasin, William E. Van Nostrand, Tsunao Saitoh, Mikhail A. Donets, E A Barnes, Wolfgang W. Quitschke, D Goldgaber · 1991 · Proceedings of the National Academy of Sciences
7. Mechanisms of memory loss in Aβ and tau mouse models
   Ashe, K.H. · 2005 · Biochemical Society Transactions
8. Nutritional factors relevant to Alzheimer’s disease
   Marilyn Smith Claggett · 1989 · Journal of the American Dietetic Association
9. The development of Alzheimer's disease in Down's syndrome assessed by auditory event‐related potentials
   Douglas Blackwood, David M. St. Clair, Walter J Muir, Chris Oliver, Paul Dickens · 1988 · Journal of Intellectual Disability Research
10. A Basic Amino Acid in the Cytoplasmic Domain of Alzheimer's β-Amyloid Precursor Protein (APP) Is Essential for Cleavage of APP at the α-Site
    Susumu Tomita, Yutaka Kirino, Toshiharu Suzuki · 1998 · Journal of Biological Chemistry
11. Cerebral Hemorrhage With Biopsy-Proved Amyloid Angiopathy
    W. H. Yong, M E Robert, Diana Lenard Secor, T. J. Kleikamp, Harry V. Vinters · 1992 · Archives of Neurology
12. Systemic manifestations of Alzheimer’s disease
    Andrea C. Baker, Li‐wen Ko, John P. Blass · 1988 · AGE
13. Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade
    Whitson, J.S., Appel, S.H. · 1995 · Neurobiology of Aging
14. Concurrent neuroborreliosis and alzheimer's disease: Analysis of the evidence
    Miguel A. Pappolla, R. Omar, Bommakanti Saran, Anne C. Andorn, M. Suarez, Charles S. Pavia, A. Weinstein, D. K. Shank, Kenneth L. Davis, Willy Burgdorfer · 1989 · Human Pathology
15. Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice
    Eun-Jeong Yang, Usman Mahmood, Hyun-Ju Kim, Moonseok Choi, Yunjung Choi, Jean‐Pyo Lee, Joo‐Youn Cho, Jin Won Hyun, Yong Sik Kim, Moon‐Jeong Chang et al. · 2018 · Free Radical Biology and Medicine
16. A novel missense variant in ACAA1 contributes to early-onset Alzheimer’s disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline
    Rongcan Luo, Yu Fan, Jing Yang, Maosen Ye, Dengfeng Zhang, Kun Guo, Xiao Li, Rui Bi, Min Xu, Lu-Xiu Yang et al. · 2021 · Signal Transduction and Targeted Therapy
17. Amyloid precursor protein is enriched in radial glia: Implications for neuronal development
    Bruce D. Trapp, P. Hauer · 1994 · Journal of Neuroscience Research
18. LRP in Alzheimer’s disease: friend or foe?
    Paula G. Ulery, Dudley K. Strickland · 2000 · Journal of Clinical Investigation
19. β-Protein deposition: a pathogenetic link between Alzheimer's disease and cerebral amyloid angiopathies
    Francisco Coria, Frances Prelli, E.M. Castan˜o, Milton Larrondo-Lillo, Jose M. Fernandez-Gonzalez, Sjoerd G. van Duinen, Gerard Th. A. M. Bots, W Luyendijk, Michael L. Shelanski, Blas Frangione · 1988 · Brain Research
20. The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease
    Lydia Hendriks, Christine Van Broeckhoven · 1996 · European Journal of Biochemistry
21. Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques.
    Miguel A. Pappolla, R A Omar, Harry V. Vinters · 1991 · PubMed Central
22. Furosemide as a Probe Molecule for the Treatment of Neuroinflammation in Alzheimer's Disease.
    Zhi-Yu Wang, Prachi Vilekar, Jun-Bo Huang, D. Weaver · 2020 · ACS Chemical Neuroscience
23. Is ammonia a pathogenetic factor in Alzheimer's disease?
    Nikolaus Seiler · 1993 · Neurochemical Research
24. Absence of mutation in the β-amyloid cDNAs cloned from the brains of three patients with sporadic Alzheimer's disease
    Michael Peter Vitek, C. G. Rasool, Frédéric J. de Sauvage, Susanne M. Vitek, Raymond T. Bartus, Bernard Beer, Robert A. Ashton, Anne-Françoise Macq, Jean‐Marie Maloteaux, Arthur J. Blume et al. · 1988 · Molecular Brain Research
25. Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein
    K. E. Wisniewski, Danuta Maślińska, T. Kitaguchi, K. S. Kim, Hans Hilmar Goebel, Matti Haltia · 1990 · Acta Neuropathologica
26. Down syndrome: Toward a molecular definition of the phenotype
    Julie R. Korenberg, Hiroko Kawashima, S. M. Pulst, Leland Allen, Ellen Magenis, Charles J. Epstein · 2005 · American Journal of Medical Genetics
27. Expression of amyloid precursor protein mRNA isoforms in rat brain is differentially regulated during postnatal maturation and by cholinergic activity
    Jenny Apelt, Reinhard Schliebs, Mike Beck, Steffen Roiner, Volker Bigl · 1997 · International Journal of Developmental Neuroscience
28. Suppression of Amyloid β A11 Antibody Immunoreactivity by Vitamin C
    Fang Cheng, Roberto Cappai, Giuseppe D. Ciccotosto, Gabriel Svensson, Gerd Multhaup, Lars‐Âke Fransson, Katrin Mani · 2011 · Journal of Biological Chemistry
29. Cell type-specific histone acetylation profiling of Alzheimer’s disease subjects and integration with genetics
    Easwaran Ramamurthy, Gwyneth Welch, Jemmie Cheng, Yixin Yuan, Laura M. Gunsalus, David Alan Bennett, Li‐Huei Tsai, Andreas R. Pfenning · 2023 · Frontiers in Molecular Neuroscience
30. Neuroinflammatory Cytokines - The Common Thread in Alzheimer Pathogenesis
    W. Sue T. Griffin, Steven W. Barger, Dillard Professor and Vice Chairman · 2011 · European Neurological Review
31. Amyloid β-peptide is produced by cultured cells during normal metabolism: A reprise
    Dennis J. Selkoe · 2006 · Journal of Alzheimer s Disease
32. Expression, purification, and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid β-protein precursor-like protein-2
    William E. Van Nostrand, Alvin H. Schmaier, Barry R. Neiditch, Robert S. Siegel, William C. Raschke, Sangram S. Sisodia, Steven L. Wagner · 1994 · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
33. Amyloid precursor-like protein 1 accumulates in neuritic plaques in Alzheimer's disease
    Thomas A. Bayer, Krzysztof Paliga, Sascha Weggen, O. D. Wiestler, Konrad Beyreuther, Gerd Multhaup · 1997 · Acta Neuropathologica
34. Alzheimer’s Disease: Genes, Pathogenesis and Risk Prediction
    Kristel Sleegers, Cornelia M. van Duijn · 2001 · Public Health Genomics
35. Displacement Currents Associated with the Insertion of Alzheimer Disease Amyloid β-Peptide into Planar Bilayer Membranes
    J. Vargas, Juan Marcos Alarcón, E. Rojas · 2000 · Biophysical Journal
36. The amyloid proteins of Alzheimer's disease as potential targets for drug therapy
    Claudia B. Caputo, Andre I. Salama · 1989 · Neurobiology of Aging
37. Abnormal and deficient processing of β-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells
    Akira Matsumoto, Yoshisada Fujiwara · 1991 · Biochemical and Biophysical Research Communications
38. Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses
    Don C. Guiroy, Richard T. Yanagihara, Daniel Carleton Gajdusek · 1991 · Acta Neuropathologica
39. Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
    Mayur Bhimrao Kale, Harshavardhan M Bhondge, Nitu L. Wankhede, Prajwali V Shende, Rushikesh Thanekar, Manish Manohar Aglawe, Sandip R. Rahangdale, Brijesh Gulabrao Taksande, Sunil B. Pandit, Aman Babanrao Upaganlawar et al. · 2024 · Ageing Research Reviews
40. Molecular Pathology of Alzheimer’s Disease and Related Disorders
    Stephen D. Ginsberg, Marie Luise Schmidt, Peter B. Crino, James H. Eberwine, Virginia M.‐Y. Lee, John Q. Trojanowski · 1999 · Cerebral cortex
41. Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer β-amyloid protein from its precursor
    JOHN R. MCDERMOTT, J.A. Biggins, ALISON M. GIBSON · 1992 · Biochemical and Biophysical Research Communications
42. Chapter 39: S100β and serotonin: a possible astrocytic-neuronal link to neuropathology of Alzheimer's disease
    Efrain C. Azmitia, W. Sue T. Griffin, Daniel R. Marshak, Linda J. Van Eldik, Patricia M. Whitaker‐Azmitia · 1992 · Progress in brain research
43. Chapter 38: The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease
    Huntington Potter · 1992 · Progress in brain research
44. Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimer's Disease
    Sam Gandy · 2012 · New England Journal of Medicine
45. Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
    Sofia Essayan-Perez, Bo Zhou, Amber M. Nabet, Marius Wernig, Yu‐Wen Alvin Huang · 2019 · Neurobiology of Disease
46. The Medical and Economic Roles of Pipeline Pharmacogenetics: Alzheimer's Disease as a Model of Efficacy and HLA-B*5701 as a Model of Safety
    Allen D. Roses · 2008 · Neuropsychopharmacology
47. Age-related cognitive decline and electroencephalogram slowing in down's syndrome as a model of Alzheimer's disease
    Hilkka S. Soininen, Juhani V Partanen, Veikko Jousmäki, E.-L. Helkala, Matti Vanhanen, S Majuri, Markus Kaski, Päivi H. Hartikainen, Paavo J. Riekkinen · 1993 · Neuroscience
48. Alzheimer plaques and tangles: advances on both fronts
    Kenneth S. Kosik · 1991 · Trends in Neurosciences
49. Molecular and cellular biology of Alzheimer amyloid
    Charles A. Marotta, Ronald E. Majocha, Barbara A. Tate · 1992 · Journal of Molecular Neuroscience
50. Biochemistry of Alzheimer's disease amyloid plaques
    Paul E. Fraser, Lyne Lévesque, Donald R. Crapper McLachlan · 1993 · Clinical Biochemistry
51. Cellular specificity and regional distribution of amyloid β protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation
    Rudolph E. Tanzi, Julie J. Wenniger, Bradley T. Hyman · 1993 · Molecular Brain Research
52. Activity of α‐Secretase as the Common Final Effector of Protein Kinase C‐Dependent and ‐Independent Modulation of Amyloid Precursor Protein Metabolism
    Marco Racchi, Daniela C. Solano, Marita Sironi, Stefano M. Govoni · 1999 · Journal of Neurochemistry
53. Genetics of Alzheimer's Disease
    Lars Bertram, Rudolph E. Tanzi · 2011 · Wiley eBooks
54. Irradiation-reduced human chromosome 21 hybrids
    Sharon Louise Graw, Jeffrey N. Davidson, James F. Gusella, Paul C. Watkins, Rudolph E. Tanzi, Rachael L. Neve, David Patterson · 1988 · Somatic Cell and Molecular Genetics
55. From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis
    Robert Kisilevsky · 1987 · Canadian Journal of Physiology and Pharmacology
56. The vexing complexity of the amyloidogenic pathway
    Manuel Castro, Arina Hadziselimovic, Charles R. Sanders · 2019 · Protein Science
57. Two nuclear factor binding domains activate expression from the human amyloid beta-protein precursor promoter.
    Wolfgang W. Quitschke · 1994 · Journal of Biological Chemistry
58. Parallel Compensatory and Pathological Events Associated with Tau Pathology in Middle Aged Individuals with Down Syndrome
    Elizabeth Head, Ira T. Lott, Patrick R. Hof, Constantin Bouras, J. Su, R. Kim, Richard J. Haier, Carl W. Cotman · 2003 · Journal of Neuropathology & Experimental Neurology
59. The Functions of the Amyloid Precursor Protein Gene
    Peter K. Panegyres · 2001 · Reviews in the Neurosciences
60. Processing of the Alzheimer's Disease ΒZA4 Amyloid Protein Precursor (APP)
    Steven G. Younkin · 1991 · Brain Pathology
61. Characterization of platelet-releasable forms of beta-amyloid precursor proteins: the effect of thrombin
    RP Smith, GJ Jr Broze · 1992 · Blood
62. Aberrant proteolysis of the β‐amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells
    Akira Matsumoto, Yoshisada Fujiwara · 1993 · European Journal of Biochemistry
63. Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease
    Flaminio Cattabeni, Francesca Colciaghi, Mónica Di Luca · 2004 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
64. Myelin Basic Protein Binds to and Inhibits the Fibrillar Assembly of Aβ42 in Vitro
    Michael D. Hoos, Mahiuddin Ahmed, Steven O. Smith, William E. Van Nostrand · 2009 · Biochemistry
65. Systemic amyloid deposition in old age and dementia of Alzheimer type: the relationship of brain amyloid to other amyloid
    Masahito Yamada, Hiroshi Tsukagoshi, Eiichi Otomo, Michio Hayakawa · 1988 · Acta Neuropathologica
66. Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules
    Christopher G. Janson, Matthew J. During · 2006 · Springer eBooks
67. Deciphering Alzheimer's disease: the pace quickens
    Dennis J. Selkoe · 1987 · Trends in Neurosciences
68. In vivo proton magnetic resonance spectroscopy study on premature aging in adult Down's syndrome
    Tetsuhito Murata, Yoshifumi Koshino, Masao Omori, Ichiro Murata, Masashi Nishio, Tan Horie, Yumiko Umezawa, Kiminori Isaki, Hirohiko Kimura, Satoshi Itoh et al. · 1993 · Biological Psychiatry
69. Expression of Presenilin 1 in nervous system during rat development
    María Teresa Moreno-Flores, Miguel Medina, Francisco G. Wandosell · 1999 · The Journal of Comparative Neurology
70. Fourteen Newly Recognized Proteins at the Human Neuromuscular Junctions‐and Their Nonjunctional Accumulation in Inclusion‐Body Myositisaa
    Valerie Askanas, W. King Engel, Renate B. Alvarez · 1998 · Annals of the New York Academy of Sciences
71. Molecular Genetics: Applications to the Clinical Neurosciences
    Joseph B. Martin · 1987 · Science
72. Rationale for the development of an Alzheimer’s disease vaccine
    Ping Kwan, Haruki Konno, Ka Yan Chan, Larry Baum · 2019 · Human Vaccines & Immunotherapeutics
73. Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective
    Rajashree Banerjee, Arushi Rai, Shreyas Iyer, Sonia Narwal, Meghana Tare · 2022 · Animal Models and Experimental Medicine
74. Characterization of Recombinant, Soluble β-Secretase from an Insect Cell Expression System
    William D. Mallender, Debra Yager, Luisa Onstead, Michael R. Nichols, Christopher B. Eckman, Kumar Sambamurti, Lisa M. Kopcho, Jovita A. Marcinkeviciene, Robert A. Copeland, Terrone L. Rosenberry · 2001 · Molecular Pharmacology
75. The chick embryo appears as a natural model for research in beta-amyloid precursor protein processing
    José Alberto Carrodeguas, Annie Rodolosse, M.V. Garza, Antonio Sanz-Clemente, Rosaura Pérez‐Pé, Ana Ma Lacosta, L. Domínguez, Inmaculada Monleón, Rosa Angélica Sánchez-Díaz, Vı́ctor Sorribas et al. · 2005 · Neuroscience
76. Alzheimer s disease and heparan sulfate proteoglycan
    Ken-ichiro Fukuchi · 1998 · Frontiers in bioscience
77. The Protease Inhibitor, α1-Antichymotrypsin, Is a Component of the Brain Amyloid Deposits in Normal Aging and Alzheimer's Disease
    Carmela R. Abraham, Huntington Potter · 1989 · Annals of Medicine
78. Coagulation Factor XIa Cleaves the RHDS Sequence and Abolishes the Cell Adhesive Properties of the Amyloid β-Protein
    Susan M. Saporito-Irwin, William E. Van Nostrand · 1995 · Journal of Biological Chemistry
79. Diagnosis of Alzheimer's Disease
    ‌Barry Reisberg, Alistair S. Burns, Henry Brodaty, Robin Eastwood, Martin N. Rossor, Norman Sartorius, Bengt G. Winblad · 1997 · International Psychogeriatrics
80. The genesis of the senile plaque. Further evidence in support of its neuronal origen
    Miguel A. Pappolla · 1992 · Neurobiology of Aging
81. Evidence of Subtypes of Alzheimer's Disease and Implications for Etiology
    William Bondareff · 1993 · Archives of General Psychiatry
82. The dark side of Alzheimer’s disease: unstructured biology of proteins from the amyloid cascade signaling pathway
    Kundlik Gadhave, Bhuvaneshwari R. Gehi, Prateek Kumar, Bin Xue, Vladimir Nikolaevich Uversky, Rajanish Giri · 2020 · Cellular and Molecular Life Sciences
83. Down syndrome is an oxidative phosphorylation disorder
    M. Pilar Bayona‐Bafaluy, Nuria Garrido-Pérez, Patricia Meade, Eldris Iglesias, Irene Jiménez-Salvador, Julio Montoya, Carmen Martínez‐Cué, Eduardo Ruiz‐Pesini · 2021 · Redox Biology
84. How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease
    Junjun Ni, Zhen Xie, Zhenzhen Quan, Jie Meng, Hong Qing · 2023 · Glia
85. Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease
    K. Das Hriday · 2007 · Frontiers in bioscience
86. Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein
    Anna Henry, Qiao‐Xin Li, Denise Galatis, Lars Hesse, Gerd Multhaup, Konrad Beyreuther, Colin Louis Masters, Roberto Cappai · 1998 · British Journal of Haematology
87. βA4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the βA4 amyloid precursor protein gene and sporadic Alzheimer's disease
    Nigel J. Cairns, Andrew J Chadwick, Peter L Lantos, Raymond Levy, Martin N. Rossor · 1993 · Neuroscience Letters
88. Ultrastructural localization of the putative precursors of the A4 amyloid protein associated with Alzheimer's disease.
    N. Catteruccia, Julia Willingale-Theune, Dirk Bunke, Reinhard Prior, Colin Louis Masters, Andrea Crisanti, Konrad T. Beyreuther · 1990 · Europe PMC (PubMed Central)
89. The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids: or, perhaps amyloid is not a misnomer
    Robert Kisilevsky, Alan D. Snow · 1988 · Medical Hypotheses
90. Secretases as therapeutic targets for the treatment of Alzheimer's disease
    Diana Ines Dominguez, Bart De Strooper, Wim G. Annaert · 2001 · Amyloid
91. Alzheimer‐related protein APL ‐1 modulates lifespan through heterochronic gene regulation in Caenorhabditis elegans
    Collin Y. Ewald, Vanessa Marfil, Chris Li · 2016 · Aging Cell
92. Amyloid-β precursor protein expression and modulation in human embryonic stem cells: A novel role for human chorionic gonadotropin
    Prashob Porayette, Miguel J. Gallego, Maria M. Kaltcheva, Sivan Vadakkadath Meethal, Craig Atwood · 2007 · Biochemical and Biophysical Research Communications
93. Alzheimer disease: An imbalance of proteolytic regulation?
    Mark A. Smith, George L. Perry · 1994 · Medical Hypotheses
94. Linking molecular motors to Alzheimer’s disease
    Gorazd Bernard Stokin, Lawrence S.B. Goldstein · 2006 · Journal of Physiology-Paris
95. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): A review of the variety in phenotypic expression
    Marjolijn Bornebroek, Joost Haan, Raymund A.C. Roos · 1999 · Amyloid
96. Genetic heterogeneity of gene defects responsible for familial Alzheimer disease
    Rudolph E. Tanzi, Sandra Marlene Gaston, Ashley Ian Bush, Donna Romano, Warren H. Pettingell, Jeffrey M. Peppercorn, Marc d. Paradis, Sarada Gurubhagavatula, Barbara Jenkins, Wilma Wasco · 1993 · Genetica
97. Genes involved in Alzheimer's disease, a survey of possible candidates
    Alessandro Serretti, Paola Artioli, Roberto Quartesan, Diana De Ronchi · 2005 · Journal of Alzheimer s Disease
98. Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and down syndrome cases
    Sachio Takashima, Hiromi Kuruta, Takashi Mito, Masatoyo Nishizawa, Tatsuhide Kunishita, Takeshi Tabira · 1990 · Brain and Development
99. Study of the phorbol ester effect on Alzheimer amyloid precursor processing: Sequence requirements and involvement of a Cholera toxin sensitive protein
    Spiros Efthimiopoulos, Kevin M. Felsenstein, Kumar Sambamurti, Nikolaos K. R K Robakis, Lorenzo M. Refolo · 1994 · Journal of Neuroscience Research
100. Presence of Immunoglobulins and Complements in the Amyloid Plaques in the Brain of Patients with Alzheimer’s Disease
     Tsuyoshi Ishii, S. Haga, Fuyuki Kametani · 1988 · Springer eBooks